Christmas Sale Anti-zika Virus(zikv)(strain Zika Sph2015) Zikv-e/envelope Protein(domain Iii) Monoclonal Antibody Store At -20°c Set [8iCcIzue]

Anti-Zika Virus Monoclonal Antibody

Our Anti-Zika Virus Monoclonal Antibody is a highly specialized tool designed for researchers and healthcare professionals dealing with the Zika Virus (ZIKV), specifically the strain Zika SPH2015. This antibody is engineered to target the Envelope Protein (Domain III) of the ZIKV, which plays a crucial role in receptor binding and membrane fusion. With its exceptional specificity and purity, this monoclonal antibody is an essential component for various research applications, including Western blotting (WB), making it a valuable asset in the fight against this virus.

Product Specifications and Features

This monoclonal antibody is produced in rabbits and is of the IgG isotype. It is conjugated to Protein A for purification, ensuring high purity and consistency. The immunogen used is recombinant ZIKV (strain Zika SPH2015) Envelope protein (Domain III, His Tag), which guarantees the antibody's specificity. The antibody is supplied at a concentration of 1 mg/mL in a 0.2 μm filtered solution in PBS buffer. It is unconjugated, allowing for flexibility in downstream applications. The antibody is stored at -20°C and remains stable for up to 12 months when properly stored, thus offering convenience and long-term use without the need for frequent reordering.

Applications and Benefits

The Anti-Zika Virus Monoclonal Antibody is ideally suited for research applications such as Western blotting, where it can be used to detect and quantify ZIKV proteins. Its high specificity and affinity make it a reliable tool for researchers studying the virus's biology, pathogenesis, and potential therapeutic targets. This antibody is also beneficial for developing diagnostic tests and vaccines, as it can be used to identify ZIKV infections and to evaluate the immune response to the virus. By providing a robust tool for research, this antibody aids in the advancement of our understanding and control of the Zika Virus, ultimately benefiting public health.